Align Technology, Inc.
ALGN
주식 순위
#1976
Align Technology, Inc. is a medical technology enterprise that develops,... Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.
주가
$150.24
마지막 동기화: 2026-10-20
시가총액
$10.67B
변동 (1일)
0.83%
변동 (1년)
10.29%
국가
US
거래 Align Technology, Inc. (ALGN)
카테고리
Healthcare
Align Technology, Inc. (ALGN)의 P/E 비율
October 2026 기준 P/E 비율 TTM: 25.08
Align Technology, Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/E (TTM) 비율은 25.08입니다. 2024년 말 기준 P/E 비율은 37.05였습니다.
Align Technology, Inc.의 P/E 비율 기록 (2000 ~ 2026)
매년 말 P/E 비율
| 연도 | P/E 비율 | 변화 |
|---|---|---|
| 2026 (TTM) | 25.08 | -9.14% |
| 2025 | 27.60 | -25.50% |
| 2024 | 37.05 | -21.25% |
| 2023 | 47.05 | 3.17% |
| 2022 | 45.61 | -32.11% |
| 2021 | 67.18 | 183.46% |
| 2020 | 23.70 | -52.65% |
| 2019 | 50.05 | 19.47% |
| 2018 | 41.89 | -45.51% |
| 2017 | 76.89 | 89.99% |
| 2016 | 40.47 | 10.64% |
| 2015 | 36.58 | 18.14% |
| 2014 | 30.96 | -56.75% |
| 2013 | 71.59 | 88.02% |
| 2012 | 38.07 | 37.29% |
| 2011 | 27.73 | 38.99% |
| 2010 | 19.95 | -150.67% |
| 2009 | -39.38 | -638.75% |
| 2008 | 7.31 | -76.70% |
| 2007 | 31.37 | -224.12% |
| 2006 | -25.27 | -108.95% |
| 2005 | 282.26 | 283.94% |
| 2004 | 73.52 | -255.13% |
| 2003 | -47.39 | 2,511.46% |
| 2002 | -1.81 | -5.45% |
| 2001 | -1.92 | 81.95% |
| 2000 | -1.05 | 0.00% |
유사 기업 또는 경쟁사의 P/E 비율
| 회사 | P/E 비율 | P/E 비율 차이 | 국가 |
|---|---|---|---|
| 33.11 | 32.03% |
US
|
|
| 21.39 | -14.71% |
IE
|
|
| 28.94 | 15.43% |
US
|
|
| 17.34 | -30.86% |
US
|
|
| - | - |
DE
|
P/E 비율 읽는 방법
P/E 비율은 회사의 주가와 주당순이익 간의 관계를 측정합니다.
낮지만 양수인 P/E는 현재 가치 대비 높은 수익을 내고 있는 저평가된 기업을 의미합니다. 높은 음수(0에 가까운) P/E는 큰 손실을 나타냅니다.
P/E가 30을 초과하거나 음수인 기업은 일반적으로 '성장주'로 간주되며, 투자자들은 향후 수익성 개선을 기대합니다.
양의 P/E가 10 미만인 기업은 일반적으로 '가치주'로 간주되며, 이미 매우 수익성이 높고 향후 큰 성장은 기대되지 않습니다.